Forma Therapeutics Holdings (FMTX) Tops Q1 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Forma Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 6, 2022 7:05 AM EDTClinical programs advancing in rare hematologic diseases and cancers
May 26 R&D Day to focus on research pipeline strategy and expanded development programs
Cash balance of $441.3 million positions company with runway through the third quarter of 2024
WATERTOWN, Mass.--(BUSINESS WIRE)-- Forma Therapeutics Holdings, Inc. (Nasdaq:... More
